Fortune 500 multinational healthcare corporation

Johnson & Johnson is a global leader in the healthcare industry, operating through two primary segments: Innovative Medicine (formerly Janssen) and MedTech. The company develops and manufactures a broad portfolio of pharmaceutical products and medical devices, focusing on therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular disease. Following the spin-off of its consumer health business (Kenvue) in 2023, J&J has sharpened its focus on high-growth, science-driven medical innovations. The corporation maintains a massive global footprint with significant investments in research and development to maintain its pipeline of first-in-class and best-in-class therapies. It is consistently ranked among the top companies in the Fortune 500 and is recognized for its long-standing history of dividend growth and financial stability.